Mentoring and Research in Patient-Oriented Cardiovascular Pharmacoepidemiology
以患者为中心的心血管药物流行病学的指导和研究
基本信息
- 批准号:10281638
- 负责人:
- 金额:$ 10.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-15 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAdverse eventAnticoagulantsAreaAtherosclerosis Risk in CommunitiesAtrial FibrillationBehavioralCancer PatientCardiovascular DiseasesCardiovascular systemCharacteristicsClinicalClinical InvestigatorComparative Effectiveness ResearchComplexDataData SourcesDisease OutcomeDrug InteractionsDrug usageEffectivenessElderlyEnvironmentFundingGenesGleanGuidelinesHeart failureHypertensionIndividualInterventionKidney DiseasesKnowledgeLeadLearningMalignant NeoplasmsManuscriptsMedicareMentorsMentorshipMethodologyMethodsMid-Career Clinical Scientist Award (K24)MinnesotaMulti-Ethnic Study of AtherosclerosisOralOutcomeParticipantPatientsPharmaceutical PreparationsPharmacoepidemiologyPharmacologic SubstancePharmacological TreatmentPharmacologyPharmacotherapyPhenotypePhysiologicalPlayPolypharmacyPopulationPopulations at RiskPrevalencePreventionPrincipal InvestigatorProteomicsPublishingQuality of CareRandomized Controlled TrialsRecurrenceResearchResearch ActivityResearch MethodologyResearch PersonnelRiskRoleSample SizeSamplingScientific Advances and AccomplishmentsStructureSupervisionSurvivorsTechniquesTestingTimeTrainingTranslational ResearchUniversitiesadverse outcomeburden of illnesscardiovascular disorder epidemiologycardiovascular disorder riskcareercareer developmentclinical epidemiologyclinical practiceclinically significantcohortcomparative effectivenesscomplex datadiabetes controleffectiveness evaluationexperienceflexibilitygraduate studenthealth literacyhuman old age (65+)improvedimproved outcomeinterestmedication compliancemultiple chronic conditionsnovelpatient orientedpatient oriented researchpatient populationpost-marketpreventprogramsprospectivepulmonary arterial hypertensionracial and ethnicrecruitresponserural disparitiesskillstraining opportunitytreatment strategyvenous thromboembolism
项目摘要
SUMMARY
This application will provide the Principal Investigator, Dr. Pamela Lutsey, with protected time and other
support to 1) accelerate a successful record of mentoring junior clinical investigators and graduate students
engaged in cardiovascular disease (CVD) patient-oriented research (POR), 2) obtain additional training in
pharmacoepidemiology, -omics and mentoring best practices and 3) advance her ongoing CVD
pharmacoepidemiology research program. Pharmaceuticals play a crucial role in the prevention and treatment
of CVD and other conditions. To improve the effectiveness of pharmacologic interventions on CVD outcomes,
we need junior clinical investigators conducting POR who have rigorous training and mentorship in the areas
of pharmacoepidemiology, clinical epidemiology of CVD, translational research methods and the use of
complex data sources. An expert in these areas, the candidate, Dr. Lutsey, proposes to apply K24 funds
toward the mentorship of POR scholars at the University of Minnesota who are committed to a research
career that will reduce the burden of CVD in the population through building rigorous evidence regarding how
to optimize use of pharmaceuticals in order to prevent CVD in at-risk populations and reduce risk of
recurrence among individuals with CVD. Aim 1 involves conducting pharmacoepidemiology POR comparative
effectiveness research to prevent CVD in at-risk populations and improve the outcomes among CVD
survivors. State-of-the-art pharmacoepidemiologic techniques will be applied to large administrative data
sources, specifically MarketScan and the Medicare 20% sample. Aim 2 will harness rich data from deeply
phenotyped cohorts to understand behavioral characteristics that influence the effectiveness of medications,
and glean added understanding of the physiologic mechanisms through which pharmacotherapies act. These
analyses will use data from the Atherosclerosis Risk in Communities (ARIC) study and the Multi-Ethnic Study
of Atherosclerosis (MESA). Findings from the proposed Aims will advance understanding of the role of specific
pharmacologic treatment strategies on CVD risk, and have potential to directly impact clinical practice,
reinforcing or leading to reconsideration of existing clinical guidelines. This proposal is structured to allow
trainees the flexibility to pursue their own hypotheses, motivated by their clinical experiences and interests.
With support from this K24, Dr. Lutsey plans to expand the breadth of her POR research activities, recruit new
junior clinical scholars into POR, and prepare them to make major scientific advances and launch their own
independent research careers.
总结
本申请将为主要研究者Pamela Lutsey博士提供受保护的时间和其他
支持1)加快指导初级临床研究者和研究生的成功记录
从事心血管疾病(CVD)患者导向研究(POR),2)获得额外的培训,
药物流行病学,组学和指导最佳实践和3)推进她正在进行的CVD
药物流行病学研究计划。药物在预防和治疗中起着至关重要的作用
CVD和其他疾病。为了提高药物干预对CVD结局的有效性,
我们需要初级临床研究人员进行POR,他们在这些领域接受过严格的培训和指导
药物流行病学,CVD的临床流行病学,转化研究方法和使用
复杂的数据源。作为这些领域的专家,候选人Lutsey博士建议申请K24基金
对明尼苏达大学致力于研究的POR学者的指导
职业生涯,将减少心血管疾病的负担,在人口通过建立严格的证据,关于如何
优化药物的使用,以预防高危人群的心血管疾病,
CVD患者的复发率。目的1涉及进行药物流行病学POR比较
在高危人群中预防CVD并改善CVD结局的有效性研究
幸存者最先进的药物流行病学技术将应用于大型管理数据
特别是MarketScan和Medicare 20%样本。Aim 2将利用丰富的数据,
表型队列以了解影响药物有效性的行为特征,
并进一步了解药物治疗的生理机制。这些
分析将使用来自社区动脉粥样硬化风险(ARIC)研究和多种族研究的数据
阿塞罗(梅萨)。从拟议目标中得出的结论将促进对具体目标的作用的理解,
药物治疗策略对CVD风险的影响,并有可能直接影响临床实践,
加强或导致重新考虑现有的临床指南。该提案的结构允许
学员的灵活性,追求自己的假设,由他们的临床经验和利益的动机。
在K24的支持下,Lutsey博士计划扩大她的POR研究活动的广度,招募新的
初级临床学者到POR,并准备他们作出重大的科学进步,并推出自己的
独立研究职业。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAMELA L. Lutsey其他文献
PAMELA L. Lutsey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAMELA L. Lutsey', 18)}}的其他基金
Mentoring and Research in Patient-Oriented Cardiovascular Pharmacoepidemiology
以患者为中心的心血管药物流行病学的指导和研究
- 批准号:
10450836 - 财政年份:2021
- 资助金额:
$ 10.42万 - 项目类别:
Mentoring and Research in Patient-Oriented Cardiovascular Pharmacoepidemiology
以患者为中心的心血管药物流行病学的指导和研究
- 批准号:
10657650 - 财政年份:2021
- 资助金额:
$ 10.42万 - 项目类别:
Sleep Disordered Breathing and Incident Cognitive Decline and Dementia: ARIC
睡眠呼吸障碍与认知衰退和痴呆症事件:ARIC
- 批准号:
8621673 - 财政年份:2013
- 资助金额:
$ 10.42万 - 项目类别:
Sleep Disordered Breathing and Incident Cognitive Decline and Dementia: ARIC
睡眠呼吸障碍与认知衰退和痴呆症事件:ARIC
- 批准号:
8738710 - 财政年份:2013
- 资助金额:
$ 10.42万 - 项目类别:
Serum Vitamin D and Cardiovascular Disease Risk in the Biethnic ARIC Cohort
双种族 ARIC 队列中的血清维生素 D 和心血管疾病风险
- 批准号:
8434290 - 财政年份:2011
- 资助金额:
$ 10.42万 - 项目类别:
Serum Vitamin D and Cardiovascular Disease Risk in the Biethnic ARIC Cohort
双种族 ARIC 队列中的血清维生素 D 和心血管疾病风险
- 批准号:
8279218 - 财政年份:2011
- 资助金额:
$ 10.42万 - 项目类别:
Serum Vitamin D and Cardiovascular Disease Risk in the Biethnic ARIC Cohort
双种族 ARIC 队列中的血清维生素 D 和心血管疾病风险
- 批准号:
8107202 - 财政年份:2011
- 资助金额:
$ 10.42万 - 项目类别:
Serum Vitamin D and Cardiovascular Disease Risk in the Biethnic ARIC Cohort
双种族 ARIC 队列中的血清维生素 D 和心血管疾病风险
- 批准号:
8471760 - 财政年份:2011
- 资助金额:
$ 10.42万 - 项目类别:
Serum Vitamin D and Cardiovascular Disease Risk in the Biethnic ARIC Cohort
双种族 ARIC 队列中的血清维生素 D 和心血管疾病风险
- 批准号:
8695445 - 财政年份:2011
- 资助金额:
$ 10.42万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 10.42万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 10.42万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 10.42万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 10.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 10.42万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 10.42万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 10.42万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 10.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 10.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 10.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)